PCA has previously been proven to decrease the expression of NF-κB in non-small-cell lung cancer (NSCLC) cell lines, A549, H3255, and Calu-6 cell lines, and the decreased NF-κB expression was associated with a reduction in IL-6 [29]. This evidence concerns the gene IL6 and non-small cell lung carcinoma.